Slow and Accelerated Rehabilitation Protocols
Launched by HACETTEPE UNIVERSITY · Jul 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different rehabilitation approaches after a surgical procedure called latissimus dorsi transfer, which is used to help people with serious shoulder injuries known as massive, irreparable rotator cuff tears. The main goal of the study is to find out whether starting physical therapy slowly or more quickly after surgery leads to less pain and better recovery.
To take part in this trial, participants need to be between 18 and 65 years old and have been diagnosed with a massive rotator cuff tear that hasn’t improved with other treatments like injections or physical therapy for at least six months. They should also speak Turkish well and have a good understanding of their mental abilities. Throughout the study, participants will engage in specific rehabilitation exercises and provide feedback on their recovery experiences. This trial is currently recruiting participants of all genders. If you or someone you know fits these criteria and is interested, this could be a valuable opportunity to contribute to understanding the best ways to recover from shoulder surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • being in the age range of 18-65 years
- • being diagnosed with massive, irreparable rotator cuff tears based on magnetic resonance imaging and clinical continuity tests
- • symptoms are unresponsive to conservative care including steroid injections and physiotherapy for at least 6 months
- • having a good command of the Turkish language
- • scoring above 24 in the Mini Mental State Test
- • ≥80% compliance in completing the post-ARCR Phase 1 trainings
- • volunteering to participate in the study
- Exclusion Criteria:
- • diabetes mellitus
- • neurological problems
- • cervical disc herniation
- • visual, verbal, and/or cognitive defects (aphasia, unilateral neglect, etc.)
- • systemic inflammatory problems
- • hypermobility, trauma, and/or inflammation that could be a contraindication for mobilization
- • former shoulder fractures on the affected side
- • advanced glenohumeral arthritis (Hamada grade 3),
- • deltoid muscle dysfunction,
- • irreparable subscapularis tears,
- • active infection,
- • shoulder stiffness,
- • a history of previous shoulder surgery
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kırşehir, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials